Completed - Monday 5 Dec 2016 to Tuesday 5 Dec 2017
QP16C08 Part A, Group 1R // Study Number: mRNA-177-P101
First round human trial for a Human Respiratory Syncytial Virus (HRSV) or Respiratory Syncytial Virus (RSV) vaccine. Completing number 21 is probably the thing that has taken the longest amount of time to complete so far, with the entirety of the medial trial taking a full 12 months from start to finish.